Recent Blog Posts

View Post: Vitamin B3 Reverses Hardening Of Arteries : Health Freedom Alliance
27 Nov 2009 by dk  
Participants were randomly assigned to receive niacin or a second cholesterol-lowering drug (ezetimibe; brand name Zetia) for an average of 14 months. Niacin was taken in the form of extended-release tablets at bedtime. ...
View Blog: Health Freedom Alliance - http://blogs.healthfreedomalliance.org/

---

View Post: Abbott Statement on ARBITER 6 - HALTS Results and Abbott's Niaspan ...
15 Nov 2009
Abbott Statement on ARBITER 6 - HALTS Results and Abbott's Niaspan (niacin extended-release). AbbottPosted on:16 Nov 09. More Abbott press releases. Study results released today by the American Heart Association and the New England ...
View Blog: Pharmaceutical Jobs - Research and Development... - http://www.pharmiweb.com/

---

View Post: Ezetimibe fails to beat niacin at reducing atherosclerosis and LDL ...
20 Nov 2009
ORLANDO (Reuters Health) - In a head-to-head comparison, extended-release niacin outperformed ezetimibe in shrinking carotid intima-media thickness in patients who were already taking statins, raising yet another red flag over ezetimibe ...
View Blog: The Doctor's Channel - http://www.thedoctorschannel.com/

---

View Post: Niacin Found to Be Better than Zetia for High Cholesterol ...
20 Nov 2009 by JUN  
According to the Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6: HDL and LDL Treatment Strategies in Atherosclerosis (ARBITER 6-HALTS) study, extended-release niacin results in significant ...
View Blog: HealthandAge - http://www.healthandage.com/

---

View Post: Niacin vs LDL cholesterol
18 Nov 2009
In total, 145 patients with clinically evident atherosclerosis were randomized to 1500 mg daily of extended-release niacin or to placebo. All patients were treated with a statin as needed to reach NCEP ATP III LDL-cholesterol targets. ...
View Blog: theHeart.org - http://www.theheart.org/

---

View Post: Abbott Statement On ARBITER 6 – HALTS Results And Abbott's Niaspan ...
16 Nov 2009 by DrugsNews  
Results from the investigator-initiated ARBITER 6 – HALTS study showed patients at high cardiovascular risk had significant regression of atherosclerosis after 8 and 14 months of therapy with Abbott's Niaspan® (niacin extended-release ...
View Blog: Drugs Reviews

---

View Post: Vitamin B Niacin Offers No Additional Benefit to Statin Therapy in ...
18 Nov 2009
The routine prescription of extended-release niacin, a B vitamin (1500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque ...
View Blog: Newswise: BizNews - http://www.newswise.com/articles/list?category=medicine/

---